This content is only available within our institutional offering.
11 Sep 2017
N+1 Singer - Morning Song 11-09-2017
GlobalData Plc (DATA:LON), 120 | EKF Diagnostics Holdings plc (EKF:LON), 28.0 | Restore PLC (RST:LON), 282 | PCI-PAL PLC (PCIP:LON), 56.5 | Realm Therapeutics (RLM:LON), 0 | Servelec Group (SERV:LON), 0 | Be Heard Group (BHRD:LON), 0 | 1Spatial Plc (SPA:LON), 68.0
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
N+1 Singer - Morning Song 11-09-2017
GlobalData Plc (DATA:LON), 120 | EKF Diagnostics Holdings plc (EKF:LON), 28.0 | Restore PLC (RST:LON), 282 | PCI-PAL PLC (PCIP:LON), 56.5 | Realm Therapeutics (RLM:LON), 0 | Servelec Group (SERV:LON), 0 | Be Heard Group (BHRD:LON), 0 | 1Spatial Plc (SPA:LON), 68.0
- Published:
11 Sep 2017 -
Author:
Singer CM Team -
Pages:
16 -
1Spatial (SPA LN) Contract win with Northern Gas Networks Ltd | Be Heard (BHRD LN) Excellent execution | EKF Diagnostics (EKF LN) Recovery phase complete, focusing on future | GlobalData (DATA LN) CFO succession planning | PCI-PAL (PCIP LN) Strongly positioned for rapid growth and increased scale | Realm Therapeutics (RLM LN) FDA gives green light for PR013 to start Phase II | Restore (RST LN) Shredding strength prompts upgrades | Servelec Group (SERV LN) Interims show return to growth, but delays in the offing |